The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...

Stock analysts at HC Wainwright reduced their FY2029 earnings estimates for Oncolytics Biotech in a research note issued on ...

H.C. Wainwright initiated coverage of Perspective Therapeutics (CATX) with a Buy rating and $10 price target Perspective is a clinical-stage ...

Equities researchers at HC Wainwright issued their FY2026 earnings estimates for Aquestive Therapeutics in a research note ...

Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...

H.C. Wainwright lowered the firm’s price target on Oculis (OCS) to $29 from $30 and keeps a Buy rating on the shares following the Q4 report.

Fintel reports that on March 11, 2025, HC Wainwright & Co. initiated coverage of Westwater Resources (NYSEAM:WWR) with a Buy ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

REDEFINE-2 results reinforce Viking Therapeutics’ (VKTX) VK2735’s potential in obesity and beyond. Assuming full adherence, Novo’s CagriSema achieved 15.7% weight loss compared to 3.1% with placebo, ...

Analyst initiates coverage of WWR with Buy rating and $2.50 PT. Westwater aims to create self-sustained graphite supply chain ...

Today, Benzinga's options scanner spotted 8 options trades for Viking Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 37% bullish and 37% bearish.

The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest cryptocurrency, broker H.C. Wainwright said in a research report Monday.